Programmdetails - 92. Jahrestagung der Deutschen Gesellschaft für Kardiologie

Postervorträge

Prävention und Risikoinflammation

Samstag, 11. April | 10:00 - 11:00 | Posterbereich 04

Vorsitz/Chair: Roland Klingenberg (Frankfurt am Main), Ursula Rauch-Kröhnert (Berlin)

Agenda

(P1535)
Tirzepatide and the Risk of Atherosclerotic Cardiovascular Events
N. Krüger (München), S. Schneeweiss (Boston, MA), S. Wang (Boston, MA)
(P1536)
Anchoring database studies in trial benchmarks: cardiovascular outcomes of Semaglutide and Tirzepatide in clinical practice
N. Krüger (München), S. Schneeweiss (Boston, MA), R. J. Desai (Boston, MA), S. Kattinakere Sreedhara (Boston, MA), A. R. Kehoe (Boston, MA), K. Fuse (Boston, MA), G. Hahn (Boston, MA), H. Schunkert (München), S. Wang (Boston, MA)
(P1537)
The 4-year follow-up of the “Jena auf Ziel” cohort reveals significant improvements in LDL-C target achievement in primary care
F. Härtel (Jena), U. Makhmudova (Berlin), J.-A. Geiling (Jena), S. Otto (Gera), C. Schulze (Jena), O. Weingärtner (Jena)
(P1538)
Optimising Lipid-Lowering Therapy for Acute Coronary Syndrome using a Decision Support System: Insights from a Cluster Randomised Trial
J. Brandts (Aachen), C. Stevens (London), J. Smith (London), M. Moreno Morales (London), B. Fotios (London), L. Janani (London), G. Kiru (London), N. Kaza (London), V. Cornelius (London), N. Poulter (London), K. Khunti (Leicester), J. McEvoy (Galway), A. Zambon (Padova), J. Lopez-Sendon (Madrid), D. Conolly (Birmingham), L. Hazell (London), K. Ray (London)
(P1539)
Optimal Timing of COVID-19 Vaccination Following Acute Myocardial Infarction
H. Kerniss (Bremen), P. Curman (Stockholm), K. Kridin (Lübeck), S. Cremer (Frankfurt am Main), B. Kattih (Frankfurt am Main), M. Papathanasiou (Frankfurt am Main), R. J. Ludwig (Lübeck), D. Leistner (Frankfurt am Main)
(P1540)
Prevalence and patterns of Aspirin intake in the German population - Insights from the German National Cohort (NAKO)
B. Abdennadher (Hamburg), B. Strauß (Hamburg), H. Brenner (Heidelberg), S. Castell (Braunschweig), N. Ebert (Düsseldorf), V. Harth (Hamburg), U. Haug (Bremen), A. M. Hauri (Braunschweig), M. Heier (Augsburg), A. Köttgen (Freiburg), L. Krist (Berlin), M. Leitzmann (Regensburg), M. Marcello Ricardo Paulista (Greifswald), R. Mikolajczyk (Halle (Saale)), N. Obi (Hamburg), P. Pendt (Greifswald), T. Pischon (Berlin), P. Schartau (Regensburg), T. Schikowski (Düsseldorf), T. Schink (Bremen), I. M. Velásquez (Berlin), S. N. Willich (Berlin), M. Wuttke (Freiburg), S. Blankenberg (Hamburg), J. T. Neumann (Hamburg)
(P1541)
Impact of diabetes on clinical and patient-reported outcomes in Octo- and Nonagenerian patients with coronary artery disease after PCI – Insights from the prospective, multicenter Cruz Senior Trial
A. Erbay (Frankfurt am Main), H. Möllmann (Dortmund), H. Rittger (Fürth), M. Landt (Bad Segeberg), T. Schmitz (Essen), J. Monsegu (Grenoble), C. Robin (Bourg en Bresse), S. Achenbach (Erlangen), A. Öner (Rostock), J. Seeger (Friedrichshafen), A. Toma (Wien), D. Bondermann (Wien), M. Valgimigli (Bern), B. Stähli (Zürich), G. Nelles (Frankfurt am Main), D. Leistner (Frankfurt am Main)